Direct analysis of mitochondrial toxicity of antiretroviral drugs

Andrea Foli, Federica Benvenuto, Giampiero Piccinini, Antonella Bareggi, Andrea Cossarizza, Julianna Lisziewicz, Franco Lori

Research output: Contribution to journalArticle

Abstract

Objectives: Mitochondrial toxicity is a serious side-effect of antiretroviral drugs, especially nucleoside reverse transcriptase inhibitors (NRTI). An in vitro assay to predict mithocondrial toxicity of in-use and developmental NRTI would be invaluable. To test the ability of a cytofluorimetric technique to predict the mitochondrial-dependent pancreatic and hepatic toxicity we used didanosine (ddl) alone or in combination with hydroxyurea (HU). Methods: The technique is based on the ability of the lipophilic cation JC-1 to enter selectively into mitochondria and change its colour as the membrane potential changes due to toxicity. Mitochondrial toxicity by HU and ddl was evaluated in pancreatic and hepatic human cell lines. The results were expressed as mitochondrial toxicity index (MTI), ranging from 0 to 100: the negative control was 0, and 100 indicating maximal toxicity. Results: Dose-dependent pancreatic toxicity of ddl was evident after 14 days of culture (MTI 34 ± 4 at 100 μM, 10 ± 4 at 10 μM, 2 ± 3 at 1 μM ddl). HU alone was not toxic (MTI 7 ± 10 at 100 μM, 2 ± 2 at 50 μM and 2 ± 4 at 10 μM HU); however, HU increased the toxicity of high, but not low, concentrations of ddl For example, the MTI of 10 μM ddl plus 50 μM HU was 54 ± 9. Negligible mitochondrial toxicity was observed in the hepatic cell line exposed to ddl alone or in combination with HU. Conclusions: This in vitro assay might have in vivo relevance. First, ddl-related pancreatitis is dose dependent, and is reported more frequently than hepatic failure, consistent with our in vitro results. Second, patients who developed pancreatitis during randomized, controlled trials were treated with HU in combination with 400 mg ddl once daily (high peak concentration of ddl in the blood). In contrast, no pancreatitis was observed when HU was combined with 200 mg ddl twice daily (low peak concentration of ddl). These in vivo results are consistent with our in vitro observation that HU increases pancreatic cell toxicity in the presence of high concentrations of ddl. The in vitro assay described here might be used to predict the mitochondrial toxicity of other NRTI, alone or in combination.

Original languageEnglish
Pages (from-to)1687-1694
Number of pages8
JournalAIDS (London, England)
Volume15
Issue number13
DOIs
Publication statusPublished - Sep 7 2001

Fingerprint

Hydroxyurea
Drug-Related Side Effects and Adverse Reactions
Reverse Transcriptase Inhibitors
Nucleosides
Pancreatitis
Hepatocytes
Didanosine
Cell Line
Poisons
Liver Failure
Membrane Potentials
Cations
Mitochondria
Randomized Controlled Trials
Color
Observation
In Vitro Techniques

Keywords

  • Combination therapy
  • FACS
  • Mitochondria
  • Reverse transcriptase inhibitors
  • Toxicity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Foli, A., Benvenuto, F., Piccinini, G., Bareggi, A., Cossarizza, A., Lisziewicz, J., & Lori, F. (2001). Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS (London, England), 15(13), 1687-1694. https://doi.org/10.1097/00002030-200109070-00012

Direct analysis of mitochondrial toxicity of antiretroviral drugs. / Foli, Andrea; Benvenuto, Federica; Piccinini, Giampiero; Bareggi, Antonella; Cossarizza, Andrea; Lisziewicz, Julianna; Lori, Franco.

In: AIDS (London, England), Vol. 15, No. 13, 07.09.2001, p. 1687-1694.

Research output: Contribution to journalArticle

Foli, A, Benvenuto, F, Piccinini, G, Bareggi, A, Cossarizza, A, Lisziewicz, J & Lori, F 2001, 'Direct analysis of mitochondrial toxicity of antiretroviral drugs', AIDS (London, England), vol. 15, no. 13, pp. 1687-1694. https://doi.org/10.1097/00002030-200109070-00012
Foli A, Benvenuto F, Piccinini G, Bareggi A, Cossarizza A, Lisziewicz J et al. Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS (London, England). 2001 Sep 7;15(13):1687-1694. https://doi.org/10.1097/00002030-200109070-00012
Foli, Andrea ; Benvenuto, Federica ; Piccinini, Giampiero ; Bareggi, Antonella ; Cossarizza, Andrea ; Lisziewicz, Julianna ; Lori, Franco. / Direct analysis of mitochondrial toxicity of antiretroviral drugs. In: AIDS (London, England). 2001 ; Vol. 15, No. 13. pp. 1687-1694.
@article{a34f80e172ca4d4bb9886706ebd628c3,
title = "Direct analysis of mitochondrial toxicity of antiretroviral drugs",
abstract = "Objectives: Mitochondrial toxicity is a serious side-effect of antiretroviral drugs, especially nucleoside reverse transcriptase inhibitors (NRTI). An in vitro assay to predict mithocondrial toxicity of in-use and developmental NRTI would be invaluable. To test the ability of a cytofluorimetric technique to predict the mitochondrial-dependent pancreatic and hepatic toxicity we used didanosine (ddl) alone or in combination with hydroxyurea (HU). Methods: The technique is based on the ability of the lipophilic cation JC-1 to enter selectively into mitochondria and change its colour as the membrane potential changes due to toxicity. Mitochondrial toxicity by HU and ddl was evaluated in pancreatic and hepatic human cell lines. The results were expressed as mitochondrial toxicity index (MTI), ranging from 0 to 100: the negative control was 0, and 100 indicating maximal toxicity. Results: Dose-dependent pancreatic toxicity of ddl was evident after 14 days of culture (MTI 34 ± 4 at 100 μM, 10 ± 4 at 10 μM, 2 ± 3 at 1 μM ddl). HU alone was not toxic (MTI 7 ± 10 at 100 μM, 2 ± 2 at 50 μM and 2 ± 4 at 10 μM HU); however, HU increased the toxicity of high, but not low, concentrations of ddl For example, the MTI of 10 μM ddl plus 50 μM HU was 54 ± 9. Negligible mitochondrial toxicity was observed in the hepatic cell line exposed to ddl alone or in combination with HU. Conclusions: This in vitro assay might have in vivo relevance. First, ddl-related pancreatitis is dose dependent, and is reported more frequently than hepatic failure, consistent with our in vitro results. Second, patients who developed pancreatitis during randomized, controlled trials were treated with HU in combination with 400 mg ddl once daily (high peak concentration of ddl in the blood). In contrast, no pancreatitis was observed when HU was combined with 200 mg ddl twice daily (low peak concentration of ddl). These in vivo results are consistent with our in vitro observation that HU increases pancreatic cell toxicity in the presence of high concentrations of ddl. The in vitro assay described here might be used to predict the mitochondrial toxicity of other NRTI, alone or in combination.",
keywords = "Combination therapy, FACS, Mitochondria, Reverse transcriptase inhibitors, Toxicity",
author = "Andrea Foli and Federica Benvenuto and Giampiero Piccinini and Antonella Bareggi and Andrea Cossarizza and Julianna Lisziewicz and Franco Lori",
year = "2001",
month = "9",
day = "7",
doi = "10.1097/00002030-200109070-00012",
language = "English",
volume = "15",
pages = "1687--1694",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "13",

}

TY - JOUR

T1 - Direct analysis of mitochondrial toxicity of antiretroviral drugs

AU - Foli, Andrea

AU - Benvenuto, Federica

AU - Piccinini, Giampiero

AU - Bareggi, Antonella

AU - Cossarizza, Andrea

AU - Lisziewicz, Julianna

AU - Lori, Franco

PY - 2001/9/7

Y1 - 2001/9/7

N2 - Objectives: Mitochondrial toxicity is a serious side-effect of antiretroviral drugs, especially nucleoside reverse transcriptase inhibitors (NRTI). An in vitro assay to predict mithocondrial toxicity of in-use and developmental NRTI would be invaluable. To test the ability of a cytofluorimetric technique to predict the mitochondrial-dependent pancreatic and hepatic toxicity we used didanosine (ddl) alone or in combination with hydroxyurea (HU). Methods: The technique is based on the ability of the lipophilic cation JC-1 to enter selectively into mitochondria and change its colour as the membrane potential changes due to toxicity. Mitochondrial toxicity by HU and ddl was evaluated in pancreatic and hepatic human cell lines. The results were expressed as mitochondrial toxicity index (MTI), ranging from 0 to 100: the negative control was 0, and 100 indicating maximal toxicity. Results: Dose-dependent pancreatic toxicity of ddl was evident after 14 days of culture (MTI 34 ± 4 at 100 μM, 10 ± 4 at 10 μM, 2 ± 3 at 1 μM ddl). HU alone was not toxic (MTI 7 ± 10 at 100 μM, 2 ± 2 at 50 μM and 2 ± 4 at 10 μM HU); however, HU increased the toxicity of high, but not low, concentrations of ddl For example, the MTI of 10 μM ddl plus 50 μM HU was 54 ± 9. Negligible mitochondrial toxicity was observed in the hepatic cell line exposed to ddl alone or in combination with HU. Conclusions: This in vitro assay might have in vivo relevance. First, ddl-related pancreatitis is dose dependent, and is reported more frequently than hepatic failure, consistent with our in vitro results. Second, patients who developed pancreatitis during randomized, controlled trials were treated with HU in combination with 400 mg ddl once daily (high peak concentration of ddl in the blood). In contrast, no pancreatitis was observed when HU was combined with 200 mg ddl twice daily (low peak concentration of ddl). These in vivo results are consistent with our in vitro observation that HU increases pancreatic cell toxicity in the presence of high concentrations of ddl. The in vitro assay described here might be used to predict the mitochondrial toxicity of other NRTI, alone or in combination.

AB - Objectives: Mitochondrial toxicity is a serious side-effect of antiretroviral drugs, especially nucleoside reverse transcriptase inhibitors (NRTI). An in vitro assay to predict mithocondrial toxicity of in-use and developmental NRTI would be invaluable. To test the ability of a cytofluorimetric technique to predict the mitochondrial-dependent pancreatic and hepatic toxicity we used didanosine (ddl) alone or in combination with hydroxyurea (HU). Methods: The technique is based on the ability of the lipophilic cation JC-1 to enter selectively into mitochondria and change its colour as the membrane potential changes due to toxicity. Mitochondrial toxicity by HU and ddl was evaluated in pancreatic and hepatic human cell lines. The results were expressed as mitochondrial toxicity index (MTI), ranging from 0 to 100: the negative control was 0, and 100 indicating maximal toxicity. Results: Dose-dependent pancreatic toxicity of ddl was evident after 14 days of culture (MTI 34 ± 4 at 100 μM, 10 ± 4 at 10 μM, 2 ± 3 at 1 μM ddl). HU alone was not toxic (MTI 7 ± 10 at 100 μM, 2 ± 2 at 50 μM and 2 ± 4 at 10 μM HU); however, HU increased the toxicity of high, but not low, concentrations of ddl For example, the MTI of 10 μM ddl plus 50 μM HU was 54 ± 9. Negligible mitochondrial toxicity was observed in the hepatic cell line exposed to ddl alone or in combination with HU. Conclusions: This in vitro assay might have in vivo relevance. First, ddl-related pancreatitis is dose dependent, and is reported more frequently than hepatic failure, consistent with our in vitro results. Second, patients who developed pancreatitis during randomized, controlled trials were treated with HU in combination with 400 mg ddl once daily (high peak concentration of ddl in the blood). In contrast, no pancreatitis was observed when HU was combined with 200 mg ddl twice daily (low peak concentration of ddl). These in vivo results are consistent with our in vitro observation that HU increases pancreatic cell toxicity in the presence of high concentrations of ddl. The in vitro assay described here might be used to predict the mitochondrial toxicity of other NRTI, alone or in combination.

KW - Combination therapy

KW - FACS

KW - Mitochondria

KW - Reverse transcriptase inhibitors

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0035823019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035823019&partnerID=8YFLogxK

U2 - 10.1097/00002030-200109070-00012

DO - 10.1097/00002030-200109070-00012

M3 - Article

C2 - 11546944

AN - SCOPUS:0035823019

VL - 15

SP - 1687

EP - 1694

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 13

ER -